HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.

AbstractBACKGROUND:
Relative wall thickness (RWT), defined as 2 times posterior wall thickness divided by the left ventricular (LV) diastolic diameter, is a measure of LV geometry and may be a marker for adverse events in patients with LV dysfunction.
OBJECTIVES:
The aim of this study was to investigate the relationship between RWT and the risk for ventricular tachyarrhythmia (VA) in patients enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study.
METHODS:
The study population comprised 1,260 patients with mild heart failure and left bundle branch block.
RESULTS:
In a multivariable model, RWT was the most powerful echocardiographic measure for estimating the risk of VAs compared with commonly used echocardiographic variables. Patients with low RWT (<0.24) had 83% (p < 0.001) increased risk for VA and 68% (p < 0.001) increase in VA risk or death (VA/death) compared with patients with higher RWT values. Each 0.01-unit decrease in RWT was associated with 12% (p < 0.001) and 10% (p < 0.001) increases in the risk of VA and VA/death, respectively. Treatment with cardiac resynchronization therapy with defibrillator (CRT-D; CRT with implantable cardioverter-defibrillator) was associated with a greater increase in RWT compared with implantable cardioverter-defibrillator at 12 months (4.6 ± 6.8% vs. 1.5 ± 2.7%; p < 0.001), and every 10% increase in RWT in CRT-D patients was associated with 34% (p = 0.027) and 36% (p = 0.009) reductions in the risk of subsequent VA and VA/death, respectively.
CONCLUSIONS:
In patients with mild heart failure and left bundle branch block, decreased RWT was associated with an increase in the risk of VA and VA/death. CRT-D therapy was associated with a favorable increase in RWT and reduction in risk of VA and VA/death. (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]; NCT00180271).
AuthorsYitschak Biton, Ilan Goldenberg, Valentina Kutyifa, Jayson R Baman, Scott Solomon, Arthur J Moss, Barbara Szepietowska, Scott McNitt, Bronislava Polonsky, Wojciech Zareba, Alon Barsheshet
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 67 Issue 3 Pg. 303-12 (Jan 26 2016) ISSN: 1558-3597 [Electronic] United States
PMID26796396 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Bundle-Branch Block (complications)
  • Cardiac Resynchronization Therapy (adverse effects, methods)
  • Defibrillators, Implantable (adverse effects)
  • Echocardiography (methods)
  • Female
  • Heart Failure (complications, diagnosis, therapy)
  • Heart Ventricles (pathology)
  • Humans
  • Male
  • Middle Aged
  • Organ Size
  • Outcome Assessment, Health Care
  • Risk Assessment (methods)
  • Risk Factors
  • Statistics as Topic
  • Tachycardia, Ventricular (epidemiology, etiology, prevention & control)
  • Ventricular Dysfunction, Left (diagnosis, etiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: